484 related articles for article (PubMed ID: 18180350)
1. Increase of virulence and its phenotypic traits in drug-resistant strains of Candida albicans.
Angiolella L; Stringaro AR; De Bernardis F; Posteraro B; Bonito M; Toccacieli L; Torosantucci A; Colone M; Sanguinetti M; Cassone A; Palamara AT
Antimicrob Agents Chemother; 2008 Mar; 52(3):927-36. PubMed ID: 18180350
[TBL] [Abstract][Full Text] [Related]
2. Characterization of biofilms in drug-sensitive and drug-resistant strains of Candida albicans.
Vavala E; Colone M; Passariello C; Celestino I; Toccacieli L; Stringaro A; Angiolella L
J Chemother; 2013 Apr; 25(2):87-95. PubMed ID: 23684356
[TBL] [Abstract][Full Text] [Related]
3. Genotypic and phenotypic characterization of Candida albicans Lebanese hospital isolates resistant and sensitive to caspofungin.
Toutounji M; Tokajian S; Khalaf RA
Fungal Genet Biol; 2019 Jun; 127():12-22. PubMed ID: 30794951
[TBL] [Abstract][Full Text] [Related]
4. Molecular mechanism of fluconazole resistance and pathogenicity attributes of Lebanese Candida albicans hospital isolates.
Fattouh N; Hdayed D; Geukgeuzian G; Tokajian S; Khalaf RA
Fungal Genet Biol; 2021 Aug; 153():103575. PubMed ID: 34033880
[TBL] [Abstract][Full Text] [Related]
5. Quercetin Assists Fluconazole to Inhibit Biofilm Formations of Fluconazole-Resistant Candida Albicans in In Vitro and In Vivo Antifungal Managements of Vulvovaginal Candidiasis.
Gao M; Wang H; Zhu L
Cell Physiol Biochem; 2016; 40(3-4):727-742. PubMed ID: 27915337
[TBL] [Abstract][Full Text] [Related]
6. Effects of fluconazole treatment of mice infected with fluconazole-susceptible and -resistant Candida tropicalis on fungal cell surface hydrophobicity, adhesion and biofilm formation.
Kanoshiki RL; de Paula SB; Santos JP; Morey AT; Souza NB; Yamauchi LM; Dias Filho BP; Yamada-Ogatta SF
Indian J Med Microbiol; 2015 Feb; 33 Suppl():97-101. PubMed ID: 25657165
[TBL] [Abstract][Full Text] [Related]
7. Loss of Upc2p-Inducible
Luna-Tapia A; Willems HME; Parker JE; Tournu H; Barker KS; Nishimoto AT; Rogers PD; Kelly SL; Peters BM; Palmer GE
mBio; 2018 May; 9(3):. PubMed ID: 29789366
[TBL] [Abstract][Full Text] [Related]
8. Vulvovaginal candidiasis: species distribution, fluconazole resistance and drug efflux pump gene overexpression.
Zhang JY; Liu JH; Liu FD; Xia YH; Wang J; Liu X; Zhang ZQ; Zhu N; Yan-Yan ; Ying Y; Huang XT
Mycoses; 2014 Oct; 57(10):584-91. PubMed ID: 24962255
[TBL] [Abstract][Full Text] [Related]
9. Biofilm formation by fluconazole-resistant Candida albicans strains is inhibited by fluconazole.
Bruzual I; Riggle P; Hadley S; Kumamoto CA
J Antimicrob Chemother; 2007 Mar; 59(3):441-50. PubMed ID: 17261564
[TBL] [Abstract][Full Text] [Related]
10. Difference in virulence between fluconazole-susceptible and fluconazole-resistant Candida albicans in a mouse model.
Schulz B; Weber K; Schmidt A; Borg-von Zepelin M; Ruhnke M
Mycoses; 2011 Sep; 54(5):e522-30. PubMed ID: 21605180
[TBL] [Abstract][Full Text] [Related]
11. Development of Anti-Virulence Approaches for Candidiasis via a Novel Series of Small-Molecule Inhibitors of
Romo JA; Pierce CG; Chaturvedi AK; Lazzell AL; McHardy SF; Saville SP; Lopez-Ribot JL
mBio; 2017 Dec; 8(6):. PubMed ID: 29208749
[No Abstract] [Full Text] [Related]
12. The efficiency of the benzothiazole APB, the echinocandin micafungin, and amphotericin B in fluconazole-resistant Candida albicans and Candida dubliniensis.
Melkusová S; Bujdáková H; Volleková A; Myoken Y; Mikami Y
Pharmazie; 2004 Jul; 59(7):573-4. PubMed ID: 15296100
[TBL] [Abstract][Full Text] [Related]
13. Antifungal activity of ribavirin used alone or in combination with fluconazole against Candida albicans is mediated by reduced virulence.
Zhang M; Yan H; Lu M; Wang D; Sun S
Int J Antimicrob Agents; 2020 Jan; 55(1):105804. PubMed ID: 31605727
[TBL] [Abstract][Full Text] [Related]
14. Requirement for Candida albicans Sun41 in biofilm formation and virulence.
Norice CT; Smith FJ; Solis N; Filler SG; Mitchell AP
Eukaryot Cell; 2007 Nov; 6(11):2046-55. PubMed ID: 17873081
[TBL] [Abstract][Full Text] [Related]
15. Activity of Allyl Isothiocyanate and Its Synergy with Fluconazole against
Raut JS; Bansode BS; Jadhav AK; Karuppayil SM
J Microbiol Biotechnol; 2017 Apr; 27(4):685-693. PubMed ID: 28138121
[TBL] [Abstract][Full Text] [Related]
16. Hyperexpression of CDRs and HWP1 genes negatively impacts on Candida albicans virulence.
Maras B; Maggiore A; Mignogna G; D'Erme M; Angiolella L
PLoS One; 2021; 16(6):e0252555. PubMed ID: 34061886
[TBL] [Abstract][Full Text] [Related]
17. Resistance mechanisms in fluconazole-resistant Candida albicans isolates from vaginal candidiasis.
Cernicka J; Subik J
Int J Antimicrob Agents; 2006 May; 27(5):403-8. PubMed ID: 16621465
[TBL] [Abstract][Full Text] [Related]
18. Identification of inhibitors of drug-resistant Candida albicans strains from a library of bicyclic peptidomimetic compounds.
Trabocchi A; Mannino C; Machetti F; De Bernardis F; Arancia S; Cauda R; Cassone A; Guarna A
J Med Chem; 2010 Mar; 53(6):2502-9. PubMed ID: 20184325
[TBL] [Abstract][Full Text] [Related]
19. ERG2 and ERG24 Are Required for Normal Vacuolar Physiology as Well as Candida albicans Pathogenicity in a Murine Model of Disseminated but Not Vaginal Candidiasis.
Luna-Tapia A; Peters BM; Eberle KE; Kerns ME; Foster TP; Marrero L; Noverr MC; Fidel PL; Palmer GE
Eukaryot Cell; 2015 Oct; 14(10):1006-16. PubMed ID: 26231054
[TBL] [Abstract][Full Text] [Related]
20. Fitness and virulence costs of Candida albicans FKS1 hot spot mutations associated with echinocandin resistance.
Ben-Ami R; Garcia-Effron G; Lewis RE; Gamarra S; Leventakos K; Perlin DS; Kontoyiannis DP
J Infect Dis; 2011 Aug; 204(4):626-35. PubMed ID: 21791665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
